Teva Finally Puts a Number on Mylan Deal, Investors Stand to Profit

Teva is a 114-year old maker of pharmaceutical generics, and they've generated lots of cash along the way. They've been coy about their intention to purchase Mylan, but now there's a healthy number on the table, and share prices are on the way up...